Of note, similar results were obtained after CLDN1 knockdown, thereby revealing CLDN1’s ability to maintain effective FGFR-signaling in IM-resistant GIST and thereby promoting FGFR-mediated survival in KIT-inhibited GIST. This evidence concerns the gene KIT and gastrointestinal stromal tumor.